Anumana, Inc.

CAMBRIDGE, MA · Founded 2020 · CIK 0001953923 · Medtech · Private

ECG algorithms for early disease diagnosis using AI

anumana.ai →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$32M
1 Form D · Nov 2022
47 months since last filing
Contracts
—
No federal contracts on record
Patents
40
13 granted · 27 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$32,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1231Cell Detect, Inc.—$2.0M
1232RADOM CORPORATION—$6.2M
1233A-SYNAPTIC CORP.—$1.7M
1234Anumana, Inc.—$32M
1235ETHOS RESEARCH AND DEVELOPMENT, LLC——
1236Scanadu Inc—$45M
1237Liquid Lung DX, Inc.—$70K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Murali AravamudanDirector · Executive Officer
  • Kyle BettigoleExecutive Officer
  • Alan ColowickDirector
  • Harris FishmanExecutive Officer
  • David GoelDirector
  • Cheranjit RihalDirector

Patents

USPTO · 13 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.